Principles of Monitoring Metastatic Disease and Chemotherapy Regimens for Recurrent or Metastatic Breast Cancer

Principles of Monitoring Metastatic Disease and Chemotherapy Regimens for Recurrent or Metastatic Breast Cancer

Bibliographic Details
Main Author:	NCCN Clinical Practice Guidelines in Oncology: Breast Cancer (Version 1.213)
Format:	Article
Language:	English
Published:	Third Party Medicine International Publishing Group Co. Limited 2013-06-01
Series:	Journal of International Translational Medicine
Online Access:	http://www.jitm.hk/EN/abstract/abstract55.shtml

Similar Items

Erratum on: Chemotherapy in metastatic NSCLC – new regimens (pemetrexed, nab-paclitaxel)
by: Frontiers in Oncology Editorial Office
Published: (2014-10-01)

Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, nab-Paclitaxel)
by: Vera eHirsh, et al.
Published: (2014-07-01)

Maintenance chemotherapy after 6 cycles of platinum-doublet regimen in anthracycline-and taxane-pretreated metastatic breast cancer
by: Eun Kyo Joung, et al.
Published: (2021-01-01)

Fulvestrant in endocrine therapy of recurrent and metastatic breast cancer
by: L Yu Vladimirova
Published: (2016-12-01)

Biomarkers for evaluating response to chemotherapy in metastatic breast cancer patients
by: Nidhal A.K. Mohammed Ali, et al.
Published: (2017-07-01)

Sequential Metastatic Breast Cancer Chemotherapy:Should the Median be the Message?
by: Su Yon eJung, et al.
Published: (2013-11-01)

Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy
by: Kazuaki Harada, et al.
Published: (2019-03-01)

Chemotherapy of metastatic colon cancer
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)

Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma
by: Luo Huang, et al.
Published: (2020-11-01)

Molecular Scoring of Hepatocellular Carcinoma for Predicting Metastatic Recurrence and Requirements of Systemic Chemotherapy
by: Naoshi Nishida, et al.
Published: (2018-09-01)

First-line chemotherapy regimens for locally advanced and metastatic pancreatic adenocarcinoma: a Bayesian analysis
by: Zhang S, et al.
Published: (2018-11-01)

An audit of the results of a triplet metronomic chemotherapy regimen incorporating a tyrosine kinase inhibitor in recurrent/metastatic head and neck cancers patients
by: Vijay M Patil, et al.
Published: (2016-01-01)

Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens
by: Pei-Jian Peng, et al.
Published: (2017-02-01)

Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer
by: Amanda Bortolini Silveira, et al.
Published: (2021-09-01)

Capecitabine maintenance therapy in patients with recurrent or metastatic breast cancer
by: W. Si, et al.
Published: (2013-12-01)

Utilization and Cost-Effectiveness Analysis of Chemotherapy for Patients with Metastatic Breast Cancer
by: Chin-Ju Tsai, et al.
Published: (2018)

Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?
by: M. E. Cazzaniga, et al.
Published: (2017-01-01)

INTEGRATION OF BEVACIZUMAB IN METASTATIC COLORECTAL CANCER CHEMOTHERAPY REGIMENS IN 2 CLINICAL CENTERS IN MOSCOW AND SAINT PETERSBURG
by: N. V. Dobrova, et al.
Published: (2015-02-01)

Efficacy and Safety of Chemotherapy Regimens in Advanced or Metastatic Bladder and Urothelial Carcinomas: An Updated Network Meta-Analysis
by: Hong-Chen Qu, et al.
Published: (2020-01-01)

Metastatic medullary thyroid cancer: a dramatic response to a systemic chemotherapy (temozolomide and capecitabine) regimen
by: Lacin S, et al.
Published: (2015-05-01)

Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients
by: Markus Kieler, et al.
Published: (2020-02-01)

Clinically Meaningful Responses to Sequential Gemcitabine-Based Chemotherapy Regimens in a Patient with Metastatic Pancreatic Cancer
by: Eiko Klimant, et al.
Published: (2013-01-01)

Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.
by: Teresa Magnes, et al.
Published: (2017-01-01)

Nimotuzumab plus platinum-based chemotherapy platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
by: Yunshu Zhu, et al.
Published: (2020-09-01)

Personalization of Chemotherapy for Metastatic Pancreatic Cancer
by: Yuriko (Ito) Sasahara, et al.
Published: (2014-07-01)

Personalization of Chemotherapy for Metastatic Pancreatic Cancer
by: Yuriko (Ito) Sasahara, et al.
Published: (2014-01-01)

Combination chemotherapy for metastatic colorectal cancer
by: Koehne Claus-Henning
Published: (2003-01-01)

Chemotherapy Options beyond the First Line in HER-Negative Metastatic Breast Cancer
by: Vito Lorusso, et al.
Published: (2020-01-01)

Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype
by: E V Karabina, et al.
Published: (2016-06-01)

Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer
by: Dabo Zhou, et al.
Published: (2019-05-01)

Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells
by: Choi Changsun, et al.
Published: (2011-08-01)

Retrospective study of the efficacy and toxicity of lobaplatin in combined chemotherapy for metastatic breast cancer
by: Wu Y, et al.
Published: (2019-06-01)

Anti-PD1 checkpoint inhibitor with or without chemotherapy for patients with recurrent and metastatic nasopharyngeal carcinoma
by: Ting Jin, et al.
Published: (2021-02-01)

Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.
by: Sofia Karageorgopoulou, et al.
Published: (2017-06-01)

Treatment of Recurrent or Metastatic Uterine Adenosarcoma
by: Michael J. Nathenson, et al.
Published: (2017-01-01)

Lobaplatin-based regimens outperform cisplatin for metastatic breast cancer after anthracyclines and taxanes treatment
by: Zhipeng Wang, et al.
Published: (2018-07-01)

Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence
by: Laura Vera-Ramirez, et al.
Published: (2018-05-01)

Metabolic comorbidities and the association with risks of recurrent metastatic disease in breast cancer survivors
by: Sumadi Lukman Anwar, et al.
Published: (2021-05-01)

The Outcome of Chemotherapy for Metastatic Extramammary Paget’s Disease
by: Hiroki Hashimoto, et al.
Published: (2021-02-01)

Management of metastatic apocrine hidradenocarcinoma with chemotherapy and radiation
by: Daniel H. Miller, et al.
Published: (2015-10-01)